Trial finds candesartan reduces cardiovascular deaths and hospital admissions in people with heart failure, but may not affect all cause mortality: Abstracted from: Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003; 362(9386): 759–66

• Book ID: 116415670
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 134 KB
• Volume: 8
• Category: Article
• ISSN: 1361-2611
• DOI: 10.1016/j.ebcm.2003.12.051